Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989
- PMID: 1396757
- DOI: 10.1007/BF01962077
Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989
Abstract
The in vitro activity of metronidazole, chloramphenicol, clindamycin and 11 beta-lactam antibiotics against 135 clinical isolates of the Bacteroides fragilis group was compared. In addition, changes in the resistance patterns of members of the Bacteroides fragilis group isolated at the Hospital Universitario San Carlos in Madrid, Spain, between 1979 and 1989 were documented. The most active beta-lactam drugs were imipenem and beta-lactamase inhibitor combinations. In 1989, however, two strains were found to be resistant to imipenem and to all other beta-lactam agents tested. There was no emergence of resistance to metronidazole. Chloramphenicol was very effective: only one resistant strain was detected in 1979 and no chloramphenicol-resistant isolates were found during the rest of the study period. An outbreak of clindamycin resistance was noted in 1982, and the first cefoxitin resistant strains were recovered in 1985. The changing patterns of susceptibility of anaerobic bacteria to antimicrobial agents and the emergence of Bacteroides fragilis strains resistant to new beta-lactam agents suggest that periodic antimicrobial susceptibility tests should be performed in order to guide the selection of antimicrobial agents for therapy.
Similar articles
-
Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain.Rev Infect Dis. 1990 Jan-Feb;12 Suppl 2:S142-51. doi: 10.1093/clinids/12.supplement_2.s142. Rev Infect Dis. 1990. PMID: 2305180
-
High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.Antimicrob Agents Chemother. 2002 Sep;46(9):2908-13. doi: 10.1128/AAC.46.9.2908-2913.2002. Antimicrob Agents Chemother. 2002. PMID: 12183246 Free PMC article.
-
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.J Antimicrob Chemother. 1999 Jan;43(1):133-6. doi: 10.1093/jac/43.1.133. J Antimicrob Chemother. 1999. PMID: 10381111
-
Mechanism of antimicrobial resistance and resistance transfer in anaerobic bacteria.Scand J Infect Dis Suppl. 1982;35:37-44. Scand J Infect Dis Suppl. 1982. PMID: 6300995 Review.
-
Antimicrobial resistance and resistance transfer in anaerobic. A review.Scand J Gastroenterol Suppl. 1984;91:21-30. Scand J Gastroenterol Suppl. 1984. PMID: 6377471 Review.
Cited by
-
In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains.Antimicrob Agents Chemother. 2001 Aug;45(8):2372-4. doi: 10.1128/AAC.45.8.2372-2374.2001. Antimicrob Agents Chemother. 2001. PMID: 11451700 Free PMC article.
-
In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain.Antimicrob Agents Chemother. 2002 Mar;46(3):892-5. doi: 10.1128/AAC.46.3.892-895.2002. Antimicrob Agents Chemother. 2002. PMID: 11850282 Free PMC article.
-
Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.Antimicrob Agents Chemother. 2008 Jul;52(7):2686-90. doi: 10.1128/AAC.00081-08. Epub 2008 May 12. Antimicrob Agents Chemother. 2008. PMID: 18474575 Free PMC article.
-
Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents.Antimicrob Agents Chemother. 1999 Sep;43(9):2320-2. doi: 10.1128/AAC.43.9.2320. Antimicrob Agents Chemother. 1999. PMID: 10471590 Free PMC article.
-
Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.Drugs. 1996 Jan;51(1):99-136. doi: 10.2165/00003495-199651010-00008. Drugs. 1996. PMID: 8741235 Review.
References
MeSH terms
Substances
LinkOut - more resources
Medical